NIH Researchers Showcase VR’s Potential for Biomedicine
BY KATHRYN DEMOTT, NEI
Virtual reality (VR) systems have hit a sweet spot. Enhancements in resolution and interactive capacity have come together at a reasonable price point. Judging from the range of VR demos at the NIH Research Festival, the NIH community has plenty of ideas for tapping into the technology’s biomedical potential.
An unusual “oral history” interview with FACS II, a fluorescence-activated cell sorter, who worked at NIH from 1976 to 1992, and played an important role in scientific advancements.
Meet your recently tenured colleagues: Kevin M. Brown (NCI-DCEG), Ahmed Gharib (NIDDK), Eytan Ruppin (NCI-CCR), Martin Schnermann (NCI-CCR), Naomi Taylor (NCI-CCR), Niraj Tolia (NIAID, pictured).
Congratulations to the Nobel laureates, including three NIH-funded winners and one NIH alum; the NIHers elected to the National Academy of Medicine; Adriaan Bax who won the 2018 Welch Chemistry Award; and Dan Kastner, the Federal Employee of the Year.
Read about the latest NIH scientific discoveries: Immune culprits linked to inflammation and bone loss in gum disease; probiotic Bacilllus eliminates Staphylococcus bacteria; broader understanding of high-impact chronic pain; novel vaccine for Lassa Fever and rabies; and more.
“Elana, you are here first and foremost to learn,” National Institute of Allergy and Infectious Diseases staff clinician Agnes Mwakingwe-Omari told me on the first day of my summer internship with the Laboratory of Malaria Immunology and Vaccinology.
NEWS FROM AND ABOUT THE SCIENTIFIC INTEREST GROUPS
Two SIGs have new names, but they are still going strong and welcome new members: The “NIH Artificial Intelligence Interest Group” (formerly the “Artificial Intelligence Robotic Pharmaceutical Screening Interest Group”) and the “Protein Trafficking and Organelle Dynamics Interest Group” (formerly the “Protein Trafficking Interest Group”).
